Your browser doesn't support javascript.
loading
The Canadian VirusSeq Data Portal & Duotang: open resources for SARS-CoV-2 viral sequences and genomic epidemiology.
Gill, Erin E; Jia, Baofeng; Murall, Carmen Lia; Poujol, Raphaël; Anwar, Muhammad Zohaib; John, Nithu Sara; Richardsson, Justin; Hobb, Ashley; Olabode, Abayomi S; Lepsa, Alexandru; Duggan, Ana T; Tyler, Andrea D; N'Guessan, Arnaud; Kachru, Atul; Chan, Brandon; Yoshida, Catherine; Yung, Christina K; Bujold, David; Andric, Dusan; Su, Edmund; Griffiths, Emma J; Van Domselaar, Gary; Jolly, Gordon W; Ward, Heather K E; Feher, Henrich; Baker, Jared; Simpson, Jared T; Uddin, Jaser; Ragoussis, Jiannis; Eubank, Jon; Fritz, Jörg H; Gálvez, José Héctor; Fang, Karen; Cullion, Kim; Rivera, Leonardo; Xiang, Linda; Croxen, Matthew A; Shiell, Mitchell; Prystajecky, Natalie; Quirion, Pierre-Olivier; Bajari, Rosita; Rich, Samantha; Mubareka, Samira; Moreira, Sandrine; Cain, Scott; Sutcliffe, Steven G; Kraemer, Susanne A; Joly, Yann; Alturmessov, Yelizar; Consortium, Cphln.
Afiliação
  • Gill EE; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Jia B; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Murall CL; Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada.
  • Poujol R; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
  • Anwar MZ; Research Centre, Montréal Heart Institute, Montréal, QC, Canada.
  • John NS; Centre for Infectious Disease Genomics and One Health, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
  • Richardsson J; Centre for Infectious Disease Genomics and One Health, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
  • Hobb A; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Olabode AS; DNAstack, Toronto, ON, Canada.
  • Lepsa A; Department of Pathology and Laboratory Medicine, Western University, ON Canada.
  • Duggan AT; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Tyler AD; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
  • N'Guessan A; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
  • Kachru A; Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montreal, QC, Canada.
  • Chan B; McGill Genome Centre, McGill University, Montréal, QC, Canada.
  • Yoshida C; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Yung CK; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Bujold D; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
  • Andric D; Indoc Systems, Toronto, ON, Canada.
  • Su E; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Griffiths EJ; Department of Human Genetics, McGill University, Montréal, QC, Canada.
  • Van Domselaar G; Canadian Centre for Computational Genomics, Montréal, QC, Canada.
  • Jolly GW; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Ward HKE; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Feher H; Centre for Infectious Disease Genomics and One Health, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
  • Baker J; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
  • Simpson JT; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
  • Uddin J; DNAstack, Toronto, ON, Canada.
  • Ragoussis J; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Eubank J; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Fritz JH; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Gálvez JH; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Fang K; McGill Genome Centre, McGill University, Montréal, QC, Canada.
  • Cullion K; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Rivera L; Department of Microbiology and Immunology, McGill Research Center on Complex Traits (MRCCT), Dahdaleh Institute of Genomic Medicine (DIGM), McGill University, Montréal, QC, Canada.
  • Xiang L; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Croxen MA; DNAstack, Toronto, ON, Canada.
  • Shiell M; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Prystajecky N; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Quirion PO; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Bajari R; Alberta Precision Laboratories, Public Health Laboratory, Edmonton, AB, Canada.
  • Rich S; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada.
  • Mubareka S; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB, Canada.
  • Moreira S; Women and Children's Health Research Institute, University of Alberta, Edmonton, AB, Canada.
  • Cain S; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Sutcliffe SG; British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, BC Canada.
  • Kraemer SA; Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Joly Y; Canadian Centre for Computational Genomics, Montréal, QC, Canada.
  • Alturmessov Y; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Consortium C; Ontario Institute for Cancer Research, Toronto, ON, Canada.
ArXiv ; 2024 May 08.
Article em En | MEDLINE | ID: mdl-38764594
ABSTRACT
The COVID-19 pandemic led to a large global effort to sequence SARS-CoV-2 genomes from patient samples to track viral evolution and inform public health response. Millions of SARS-CoV-2 genome sequences have been deposited in global public repositories. The Canadian COVID-19 Genomics Network (CanCOGeN - VirusSeq), a consortium tasked with coordinating expanded sequencing of SARS-CoV-2 genomes across Canada early in the pandemic, created the Canadian VirusSeq Data Portal, with associated data pipelines and procedures, to support these efforts. The goal of VirusSeq was to allow open access to Canadian SARS-CoV-2 genomic sequences and enhanced, standardized contextual data that were unavailable in other repositories and that meet FAIR standards (Findable, Accessible, Interoperable and Reusable). In addition, the Portal data submission pipeline contains data quality checking procedures and appropriate acknowledgement of data generators that encourages collaboration. From inception to execution, the portal was developed with a conscientious focus on strong data governance principles and practices. Extensive efforts ensured a commitment to Canadian privacy laws, data security standards, and organizational processes. This Portal has been coupled with other resources like Viral AI and was further leveraged by the Coronavirus Variants Rapid Response Network (CoVaRR-Net) to produce a suite of continually updated analytical tools and notebooks. Here we highlight this Portal, including its contextual data not available elsewhere, and the 'Duotang', a web platform that presents key genomic epidemiology and modeling analyses on circulating and emerging SARS-CoV-2 variants in Canada. Duotang presents dynamic changes in variant composition of SARS-CoV-2 in Canada and by province, estimates variant growth, and displays complementary interactive visualizations, with a text overview of the current situation. The VirusSeq Data Portal and Duotang resources, alongside additional analyses and resources computed from the Portal (COVID-MVP, CoVizu), are all open-source and freely available. Together, they provide an updated picture of SARS-CoV-2 evolution to spur scientific discussions, inform public discourse, and support communication with and within public health authorities. They also serve as a framework for other jurisdictions interested in open, collaborative sequence data sharing and analyses.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article